Sae-Won Han

Sae-Won Han

Seoul National University

H-index: 61

Asia-South Korea

About Sae-Won Han

Sae-Won Han, With an exceptional h-index of 61 and a recent h-index of 35 (since 2020), a distinguished researcher at Seoul National University, specializes in the field of Medical Oncology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Pragmatic Nationwide Master Observational Trial Based on Genomic Alterations in Advanced Solid Tumors: KOrean Precision Medicine Networking Group Study of MOlecular profiling …

Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial

A Phase 1b/2a Study of GC1118 with 5-Fluorouracil, Leucovorin and Irinotecan (FOLFIRI) in Patients with Recurrent or Metastatic Colorectal Cancer

Efficacy and safety of LY3537982, a potent and highly selective KRAS G12C inhibitor in KRAS G12C-mutant GI cancers: Results from a phase 1 study.

Abstract CT029: Phase Ib study of GDC-6036 in combination with cetuximab in patients with colorectal cancer (CRC) with KRAS G12C mutation

Prognostic impact of extramural lymphatic, vascular, and perineural invasion in stage II colon cancer: a comparison with intramural invasion

Personalised circulating tumour DNA assay with large-scale mutation coverage for sensitive minimal residual disease detection in colorectal cancer

Abstract CT028: A first-in-human phase 1 study of LY3537982, a highly selective and potent KRAS G12C inhibitor in patients with KRAS G12C-mutant advanced solid tumors

Sae-Won Han Information

University

Position

Associate Professor of Internal Medicine, Seoul National University Hospital

Citations(all)

12269

Citations(since 2020)

5417

Cited By

9142

hIndex(all)

61

hIndex(since 2020)

35

i10Index(all)

202

i10Index(since 2020)

147

Email

University Profile Page

Seoul National University

Google Scholar

View Google Scholar Profile

Sae-Won Han Skills & Research Interests

Medical Oncology

Top articles of Sae-Won Han

Title

Journal

Author(s)

Publication Date

Pragmatic Nationwide Master Observational Trial Based on Genomic Alterations in Advanced Solid Tumors: KOrean Precision Medicine Networking Group Study of MOlecular profiling …

Sun Young Kim

Jee Hyun Kim

Tae-Yong Kim

Sook Ryun Park

Shinkyo Yoon

...

2024/1/9

Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial

Nature Medicine

Jayesh Desai

Guzman Alonso

Se Hyun Kim

Andres Cervantes

Thomas Karasic

...

2024/1

A Phase 1b/2a Study of GC1118 with 5-Fluorouracil, Leucovorin and Irinotecan (FOLFIRI) in Patients with Recurrent or Metastatic Colorectal Cancer

Cancer Research and Treatment: Official Journal of Korean Cancer Association

Keun-Wook Lee

Sae-Won Han

Tae Won Kim

Joong Bae Ahn

Ji Yeon Baek

...

2024/4

Efficacy and safety of LY3537982, a potent and highly selective KRAS G12C inhibitor in KRAS G12C-mutant GI cancers: Results from a phase 1 study.

Antoine Hollebecque

Yasutoshi Kuboki

Yonina R Murciano-Goroff

Rona Yaeger

Philippe Alexandre Cassier

...

2024/1/20

Abstract CT029: Phase Ib study of GDC-6036 in combination with cetuximab in patients with colorectal cancer (CRC) with KRAS G12C mutation

Cancer Research

Jayesh Desai

Sae-Won Han

Jong-Seok Lee

Einat Shacham-Shmueli

Erminia Massarelli

...

2023/4/14

Prognostic impact of extramural lymphatic, vascular, and perineural invasion in stage II colon cancer: a comparison with intramural invasion

Diseases of the Colon & Rectum

Sang Sik Cho

Ji Won Park

Gyeong Hoon Kang

Jung Ho Kim

Jeong Mo Bae

...

2023/3/1

Personalised circulating tumour DNA assay with large-scale mutation coverage for sensitive minimal residual disease detection in colorectal cancer

British journal of cancer

Seung-Bum Ryoo

Sunghoon Heo

Yoojoo Lim

Wookjae Lee

Su Han Cho

...

2023/8/10

Abstract CT028: A first-in-human phase 1 study of LY3537982, a highly selective and potent KRAS G12C inhibitor in patients with KRAS G12C-mutant advanced solid tumors

Cancer Research

Yonina R Murciano-Goroff

Rebecca S Heist

Yasutoshi Kuboki

Takafumi Koyama

Natraj Reddy Ammakkanavar

...

2023/4/14

Destabilizing NF1 variants act in a dominant negative manner through neurofibromin dimerization

Proceedings of the National Academy of Sciences

Lucy C Young

Ruby Goldstein de Salazar

Sae-Won Han

Zi Yi Stephanie Huang

Alan Merk

...

2023/1/31

Total neoadjuvant therapy with short-course radiotherapy Versus long-course neoadjuvant chemoradiotherapy in Locally Advanced Rectal cancer, Korean trial (TV-LARK trial): study …

BMC cancer

Min Jung Kim

Dae Won Lee

Hyun-Cheol Kang

Ji Won Park

Seung-Bum Ryoo

...

2023/8/8

Clinicopathological and molecular features of genome-stable colorectal cancers

Lingyan Jin

Hye-Yeong Jin

Younghoon Kim

Nam-Yun Cho

Jeong-Mo Bae

...

2023/10/31

Utilizing plasma circulating tumor DNA sequencing for precision medicine in the management of solid cancers

Cancer Research and Treatment: Official Journal of Korean Cancer Association

Yongjun Cha

Sheehyun Kim

Sae-Won Han

2023/4

Mutational evolution after chemotherapy‐progression in metastatic colorectal cancer revealed by circulating tumor DNA analysis

International Journal of Cancer

Sheehyun Kim

Yongjun Cha

Yoojoo Lim

Hanseong Roh

Jun‐Kyu Kang

...

2023/8/1

Standard versus longer interval of radical resection after neoadjuvant chemoradiotherapy in locally advanced rectal cancer: A 20‐year single‐center experience & propensity …

Journal of Surgical Oncology

Saule Khamzina

Jongoh Lee

Seung‐Bum Ryoo

Min Jung Kim

Ji Won Park

...

2023/1

Epigenetic insights into colorectal cancer: comprehensive genome-wide DNA methylation profiling of 294 patients in Korea

BMB reports

Soobok Joe

Jinyong Kim

Jin-Young Lee

Jongbum Jeon

Iksu Byeon

...

2023/10/10

Predicting the chemotherapeutic response of colorectal cancer liver metastasis using shear-wave elastography

Ultrasonography

Jae Seok Bae

Jae Young Lee

Dong Ho Lee

Sae-Won Han

Yoojoo Lim

...

2023/7

A phase II trial of S-1 and oxaliplatin in patients with metastatic breast cancer previously treated with anthracycline and taxane (KCSG-BR07-03)

Cancer Research and Treatment: Official Journal of Korean Cancer Association

Dae-Won Lee

Bhumsuk Keam

Keun Seok Lee

Jin-Hee Ahn

Joohyuk Sohn

...

2023/4

Phase 1 Study of No-Carrier Added 177Lu-DOTATATE (SNU-KB-01) in Patients with Somatostatin Receptor–Positive Neuroendocrine Tumors: The First Clinical Trial of Peptide Receptor …

Cancer Research and Treatment: Official Journal of Korean Cancer Association

Hyun Gee Ryoo

Minseok Suh

Keon Wook Kang

Dae-Won Lee

Sae-Won Han

...

2023/1

658MO Phase I study of SHR-A2009, a HER3-targeted ADC, in advanced solid tumors

Annals of Oncology

Q Zhou

YL Wu

J Li

A Liu

J Cui

...

2023/10/1

Circulating tumor DNA dynamics and treatment outcome of Regorafenib in metastatic colorectal cancer

Cancer Research and Treatment: Official Journal of Korean Cancer Association

Dae-Won Lee

Yoojoo Lim

Hwang-Phill Kim

Su Yeon Kim

Hanseong Roh

...

2023/7

See List of Professors in Sae-Won Han University(Seoul National University)